Mackay Shields LLC Ionis Pharmaceuticals Inc Transaction History

Mackay Shields LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 01, 2019	SELL	$59.06 - $72.15 $1.02 Million - $1.24 Million	-17,220 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$62.09 - $86.14 $1.47 Million - $2.03 Million	-23,601 Reduced 57.82%	17,220 $1.11 Million
Q1 2019 May 15, 2019	SELL	$52.92 - $81.17 $1.55 Billion - $2.37 Billion	-29,219,000 Reduced 99.86%	40,821 $3.31 Million
Q1 2019 May 13, 2019	BUY	$52.92 - $81.17 $1.55 Billion - $2.37 Billion	29,226,200 Added 86928.41%	29,259,821 $42.9 Million
Q4 2018 Feb 14, 2019	BUY	$43.37 - $59.54 $1.46 Million - $2 Million	33,621 New	33,621 $1.82 Million

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.